Cargando…

The Role of γδ T Cells as a Line of Defense in Viral Infections after Allogeneic Stem Cell Transplantation: Opportunities and Challenges

In the complex interplay between inflammation and graft-versus-host disease (GVHD) after allogeneic stem cell transplantation (allo-HSCT), viral reactivations are often observed and cause substantial morbidity and mortality. As toxicity after allo-HSCT within the context of viral reactivations is ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janssen, Anke, van Diest, Eline, Vyborova, Anna, Schrier, Lenneke, Bruns, Anke, Sebestyen, Zsolt, Straetemans, Trudy, de Witte, Moniek, Kuball, Jürgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779492/ https://www.ncbi.nlm.nih.gov/pubmed/35062321 http://dx.doi.org/10.3390/v14010117

Ejemplares similares

γ9δ2 T-Cell Expansion and Phenotypic Profile Are Reflected in the CDR3δ Repertoire of Healthy Adults
por: Vyborova, Anna, et al.
Publicado: (2022)

GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR
por: Straetemans, Trudy, et al.
Publicado: (2018)

Cancer Immunotherapy Using γδT Cells: Dealing with Diversity
por: Scheper, Wouter, et al.
Publicado: (2014)

Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies
por: Meringa, A. D., et al.
Publicado: (2023)

Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control
por: Johanna, Inez, et al.
Publicado: (2021)

Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model
por: Braham, Maaike V. J., et al.
Publicado: (2018)

Orchestrating an immune response against cancer with engineered immune cells expressing αβTCRs, CARs, and innate immune receptors: an immunological and regulatory challenge
por: de Witte, Moniek A., et al.
Publicado: (2015)

Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds
por: van Diest, Eline, et al.
Publicado: (2021)

Evaluating in vivo efficacy – toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells
por: Johanna, Inez, et al.
Publicado: (2019)

Vaccine Responses in Adult Hematopoietic Stem Cell Transplant Recipients: A Comprehensive Review
por: Janssen, Michelle, et al.
Publicado: (2021)

Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells
por: Kierkels, Guido J.J., et al.
Publicado: (2021)

Editorial: γδ T Cells in Cancer
por: Coffelt, Seth B., et al.
Publicado: (2020)

Multifunctional γδ T cells and their receptors for targeted anticancer immunotherapy
por: Scheper, Wouter, et al.
Publicado: (2013)

Allogeneic Stem Cell Transplantation Platforms With Ex Vivo and In Vivo Immune Manipulations: Count and Adjust
por: de Witte, Moniek, et al.
Publicado: (2021)

Serpin B9 controls tumor cell killing by CAR T cells
por: Kimman, Thomas, et al.
Publicado: (2023)

γδ T cell exhaustion: Opportunities for intervention
por: Chen, Di, et al.
Publicado: (2022)

Characterization of Donor Variability for γδ T Cell ex vivo Expansion and Development of an Allogeneic γδ T Cell Immunotherapy
por: Burnham, Rebecca E., et al.
Publicado: (2020)

Hepatocellular carcinoma‐infiltrating γδ T cells are functionally defected and allogenic Vδ2(+) γδ T cell can be a promising complement
por: He, Wenjing, et al.
Publicado: (2022)

Allogenic γδ T cell and tumor cell fused vaccine for enhanced immunotherapeutic efficacy of osteosarcoma
por: Wang, Yitian, et al.
Publicado: (2018)

Lymphopenia in COVID-19: γδ T Cells-Based Therapeutic Opportunities
por: Lo Presti, Elena, et al.
Publicado: (2021)

Graft engineering: how long can you wait, how low can you go, and pandemic readiness
por: Nijssen, Klaartje, et al.
Publicado: (2023)

The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy
por: Legut, Mateusz, et al.
Publicado: (2015)

Donor γδT Cells Promote GVL Effect and Mitigate aGVHD in Allogeneic Hematopoietic Stem Cell Transplantation
por: Song, Yuan, et al.
Publicado: (2020)

Tafasitamab mediates killing of B-cell non-Hodgkin’s lymphoma in combination with γδ T cell or allogeneic NK cell therapy
por: Her, Jung Hyun, et al.
Publicado: (2022)

High Incidence of Herpes Zoster in Patients Using Ruxolitinib for Myeloproliferative Neoplasms: Need for Prophylaxis
por: te Linde, Elsemieke, et al.
Publicado: (2022)

The evolution of malignant and reactive γδ + T cell clones in a relapse T-ALL case after allogeneic stem cell transplantation
por: Chen, Shaohua, et al.
Publicado: (2013)

Human allogenic γδ T cells kill patient-derived glioblastoma cells expressing high levels of DNAM-1 ligands
por: Choi, Haeyoun, et al.
Publicado: (2022)

Anti-thymocyte globulin with CsA and MMF as GVHD prophylaxis in nonmyeloablative HLA-mismatched allogeneic HCT
por: van der Velden, Walter J. F. M., et al.
Publicado: (2021)

Interplay between γδT-Cell Metabolism and Tumour Microenvironment Offers Opportunities for Therapeutic Intervention
por: Barisa, Marta, et al.
Publicado: (2021)

The Aging of γδ T Cells
por: Xu, Weili, et al.
Publicado: (2020)

Peripheral blood monocytes are responsible for γδ T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP
por: Roelofs, Anke J, et al.
Publicado: (2009)

The making of multivalent gamma delta TCR anti-CD3 bispecific T cell engagers
por: van Diest, Eline, et al.
Publicado: (2023)

Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models
por: Nishimoto, Kevin P, et al.
Publicado: (2022)

Interleukin‐17‐producing γδ T (γδ17) cells in inflammatory diseases
por: Akitsu, Aoi, et al.
Publicado: (2018)

Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy
por: Oberg, Hans-Heinrich, et al.
Publicado: (2014)

Our evolving understanding of the role of the γδ T cell receptor in γδ T cell mediated immunity
por: Gully, Benjamin S., et al.
Publicado: (2021)

Spleen tyrosine kinase mediates the γδTCR signaling required for γδT cell commitment and γδT17 differentiation
por: Muro, Ryunosuke, et al.
Publicado: (2023)

Reducing distress in cancer patients—A preliminary evaluation of short‐term coaching by expert volunteers
por: Post, Lenneke, et al.
Publicado: (2019)

γδ T cells take on CMV
por: Van Epps, Heather L.
Publicado: (2005)

γδ T-cells in HIV infection
por: Holt, NG, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ms5i4cdog2undo09roo900v6uo